Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
...ecretary until January 31, 2009. Prior to joining Alfacell, he served as executive vice president, chief financial officer and corporate secretary of neopharm
Inc. since 2000. From 1988 until 2000, Mr. Kenyon held a variety of senior executive positions with Mathers & Company, Inc. and its affiliated co...
DATATRAK Announces Restructured Senior Management Team
...n of the Board of DATATRAK International, Inc. Mr.
Birch has served on the DATATRAK board for the past year and is also
currently President and CEO of neopharm
Inc., a research and drug
development company. Previously, Mr. Birch was President and CEO of Askys
Ltd., a home hemodialysis company.
In another ke...
VC Community Shares Perspectives on Midwest Life Science Funding
...in the U.S.
The Midwest has three company stocks listed in this index. While not great, this at least is a start. They are MGI Pharma in Minnesota, neopharm
in Illinois and Northfield Labs in Illinois.
As more than 90 percent of our Midwest array of 350 or so biotech companies are privately held compani...
Midwest shares in stock-market bloodshed as biotechs falter
...ement strife. Its new CEO (a former Baxter senior executive) left after a short stint in the position. This was followed quickly by the departure of a neopharm
vice president of regulatory affairs. Other companies seemed caught up in the downdraft not so much as intrinsic product development issues but becaus...
Why are new drugs failing?
...ffects of key drugs.
While this approach has been useful particularly for cancer drugs, it seems to have limited impact beyond this class of drugs. neopharm
in Lake Forest, Ill. has been a leader in this arena using its lipid-based systems. More recently, American Pharmaceutical Partners has been another l...
A Midwest small-cap, life-science surprise package
... $ 77 22. BioSante (BPA) Illinois $2.77 $3.52 $ 65 23. neopharm
(NEOL) Illinois $1.67 $10.96 $ 47 24. Urologix (ULGX) Min...news of late stage product failures at the FDA for both Northfield Labs and neopharm
cratered the stocks of these companies, a number of Midwest Small Cap Life ...